Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RRM1 | P23921 | 1/20 | 0.44 |
| ▸ | GLP1R | P43220 | 8/20 | 0.42 |
| ▸ | C3AR1 | Q16581 | 1/20 | 0.42 |
| ▸ | ALB | P02768 | 4/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21792191 | 0.82 | ALDH1A1 (0.47) | RRM1ALB | |
| SCHEMBL30757553 | 0.80 | GLP1R (0.55) | GLP1RALBFOLH1 | |
| SCHEMBL12171769 | 0.80 | GLP1R (0.55) | GLP1RALBFOLH1 | |
| SCHEMBL15806590 | 0.76 | GLP1R (0.54) | GLP1RALBFOLH1 | |
| SCHEMBL22408648 | 0.76 | TLR2 (0.57) | KMT2A | |
| SCHEMBL22408647 | 0.76 | TLR2 (0.57) | KMT2A | |
| SCHEMBL18171056 | 0.76 | TLR2 (0.57) | KMT2A | |
| SCHEMBL21223782 | 0.76 | TLR2 (0.57) | KMT2A | |
| SCHEMBL22654312 | 0.76 | TLR2 (0.57) | KMT2A | |
| SCHEMBL31259011 | 0.76 | TLR2 (0.57) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4598586-A1 | DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF | Ambrx, Inc. (US) | 2025-08-13 | — | — | EP | disclosed |
| WO-2024077277-A1 | DRUG LINKERS AND ANTIBODY CONJUGATES THEREOF | AMBRX, INC. (US) | 2024-04-11 | — | — | WO | disclosed |